Markers of inflammation and weight change in middle-aged adults: Results from the prospective MONICA/KORA S3/F3 Study

Obesity

Volumn 18, Issue 12, 2010, Pages 2347-2353

  Holz, Thomas ^a   Thorand, Barbara ^a   Döring, Angela ^a   Schneider, Andrea ^a   Meisinger, Christine ^a,b   Koenig, Wolfgang ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY; RISK; SMOKING; SMOKING CESSATION; WEIGHT GAIN;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; SMOKING; SMOKING CESSATION; WEIGHT GAIN;

EID: 78649962878     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.73     Document Type: Article

References (33)

1. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369.
2. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397.
3. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823.
4. Stern M P. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44:369-374.
5. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355.
6. Tracy R P. Inflammation in cardiovascular disease: cart, horse or both-revisited. Arterioscler Thromb Vasc Biol 2002;22:1514-1515.
7. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005;48:1038-1050.
8. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005;183:308-315.
9. Wärnberg J, Nova E, Moreno LA et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 2006;84:505-512.
10. Thorand B, Baumert J, Döring A et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216-224.
11. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953-966.
12. Duncan BB, Schmidt MI, Chambless LE et al. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults-the ARIC study. Atherosclerosis Risk in Communities. Obes Res 2000;8:279-286.
13. Barinas-Mitchell E, Cushman M, Meilahn EN, Tracy R P, Kuller LH. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Am J Epidemiol 2001;153:1094-1101.
14. Engström G, Hedblad B, Stavenow L et al. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003;52:2097-2101.
15. Barzilay JI, Forsberg C, Heckbert SR, Cushman M, Newman AB. The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study. Int J Obes (Lond) 2006;30:1362-1367.
16. WHO MONICA Project Principal Investigators (prepared by H.Tunstall-Pedoe). The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): A major international collaboration. J Clin Epidemiol 1988;41:105-114.
17. Meisinger C, Thorand B, Schneider A et al. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 2002;162:82-89.
18. Hense HW, Filipiak B, Döring A et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany. Results from the 1984/85, 1989/90 and 1994/1995 surveys. CVD Prev 1998;1:318-327.
19. Hutchinson WL, Koenig W, Fröhlich M et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46:934-938.
20. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Heiss G. Inflammation markers predict increased weight gain in smoking quitters. Obes Res 2003;11:1339-1344.
21. Festa A, D'Agostino R Jr, Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-1415.
22. Weisberg S P, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808.
23. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
24. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-671.
25. Inui A, Meguid MM. Cachexia and obesity: two sides of one coin? Curr Opin Clin Nutr Metab Care 2003;6:395-399.
26. Seals DR, Bell C. Chronic sympathetic activation: consequence and cause of age-associated obesity? Diabetes 2004;53:276-284.
27. Xu H, Barnes G T, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
28. Lam QL, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007;4:1-13.
29. Brandacher G, Hoeller E, Fuchs D, Weiss HG. Chronic immune activation underlies morbid obesity: is IDO a key player? Curr Drug Metab 2007;8:289-295.
30. Fröhlich M, Sund M, Löwel H et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 2003;24:1365-1372.
31. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388.
32. Liu RH, Mizuta M, Matsukura S. The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J Pharmacol Exp Ther 2004;310:52-58.
33. Nordstrom BL, Kinnunen T, Utman CH, Garvey AJ. Long-term effects of nicotine gum on weight gain after smoking cessation. Nicotine Tob Res 1999;1:259-268.